Holen Sie sich die Stockscreener-App
361.78
0.15%
-0.53
Handel nachbörslich:
360.96
-0.82
-0.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$362.31
Offen:
$363.78
24-Stunden-Volumen:
501.42K
Relative Volume:
0.75
Marktkapitalisierung:
$25.46B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
48.36
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
+1.85%
1M Leistung:
+2.46%
6M Leistung:
+52.63%
1J Leistung:
+41.96%
1-Tages-Spanne:
$361.05
$366.12
1-Wochen-Bereich:
$354.65
$370.67
52-Wochen-Spanne:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
361.78 | 24.37B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
401.65 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.70 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
223.61 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.87 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
31.96 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical stock gains after insider sale and strong Q2 figures - ad-hoc-news.de
West Pharmaceutical Services senior VP favorite sells $2.77m in stock - investing.com
West Pharmaceutical stock heads into the open after a 0.7 percent dip - ad-hoc-news.de
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $2.7M - TradingView
West Pharmaceutical (NYSE: WST) HR chief sells stock outside a 10b5-1 plan - Stock Titan
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical CEO Michel Lagarde Granted Stock Options and RSUs in September 2026 - Kalkine Media
West Pharmaceutical (NYSE: WST) awards CEO 37K options and 14.8K RSUs vesting through 2031 - Stock Titan
West Pharmaceutical (NYSE: WST) CEO discloses initial 7,850-share stake - Stock Titan
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts By Investing.com - Investing.com Nigeria
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down - Zacks Investment Research
West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts - investing.com
West Pharmaceutical stock gains as UBS lifts price target to USD 415 - ad-hoc-news.de
Is West Pharmaceutical Services (WST) Stock A Bargain Or Fully Priced? - webull.com
West Pharmaceutical stock heads before the bell after a 0.8 percent drop - ad-hoc-news.de
West Pharmaceutical (NYSE:WST): Has the Growth Story Been Priced In? - Kalkine Media
West Pharmaceutical stock gains after strong Q2 figures - ad-hoc-news.de
Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - indexbox.io
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - ad-hoc-news.de
West Pharma Sets September Investor Conference Appearances - MyChesCo
West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - ad-hoc-news.de
West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS
West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS
West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
16,794 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Cibc World Market Inc. - MarketBeat
West (WST) Stock May Be Trading At A Premium To Fair Value - Yahoo Finance
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. (WPS) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock holds firm after Q2 beat - Ad-hoc-news.de
NFJ Investment Group LLC Invests $7.76 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 6,440 West Pharmaceutical Services, Inc. $WST - MarketBeat
2,043,823 Shares in West Pharmaceutical Services, Inc. $WST Bought by Bank of New York Mellon Corp - MarketBeat
West Pharmaceutical Services (WST) Gains Momentum On An Undervalued Narrative - Yahoo Finance
West Pharmaceutical stock holds firm as analysts lift targets - Ad-hoc-news.de
Madison Asset Management LLC Invests $9.90 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $67.58 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
West Pharmaceutical Services Inc-Aktie (WST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 11 '26 |
Option Exercise |
89.64 |
2,500 |
224,100 |
24,318 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 14 '26 |
Option Exercise |
89.64 |
2,500 |
224,100 |
24,318 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 15 '26 |
Sale |
365.00 |
2,524 |
921,260 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 14 '26 |
Sale |
355.00 |
2,500 |
887,500 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 11 '26 |
Sale |
345.00 |
2,500 |
862,500 |
21,818 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 08 '26 |
Option Exercise |
85.37 |
8,135 |
694,453 |
19,663 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Sep 08 '26 |
Sale |
340.81 |
8,135 |
2,772,489 |
16,845 |
1.01%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):